Copilot
Your everyday AI companion
About 668,000 results
  2. The US Food and Drug Administration approved the first vaccine against respiratory syncytial virus, known as RSV, and vaccines are in the works. Erskin. L. Palmer/CDC CNN — After a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV – and more are on the way.

    FDA approves first vaccine for RSV, a moment six decades in the ...

    www.cnn.com/2023/05/03/health/first-rsv-vaccine-approved/index.html
    www.cnn.com/2023/05/03/health/first-rsv-vaccine-approved/index.html
    Was this helpful?
  3. People also ask
    Is a surge in respiratory syncytial virus infections affecting healthcare systems?
    A surge in respiratory syncytial virus (RSV) infections and RSV-related hospitalizations in the 2023 Southern Hemisphere winter, similar to that seen in 2022 in northern climes, has strained already fragile healthcare systems that are also coping with the influenza season and COVID-19.

    Progress at last against RSV | Nature Medicine

    nature.com
    What are the virulence factors of respiratory syncytial virus and how do they affect the host?

    Dr. Spoorthi Prakash

    MBBS · 8 years of exp

    The human respiratory syncytial virus is one of the most common respiratory viruses affecting children and elderly and results in large out-patient visits and admissions every year. There are various strategies that virus incorporates the host immune system, thus spreading more easily which is called virulence. There are various modifications of the proteins inside the virus, which makes the host not recognize and fight the virus, thus virus spreads without any opposition and causes long time effects like asthma and allergic bronchitis.
    Q&A: Human Respiratory Syncytial Virus
    microsoftstart.msn.com
    What does a human respiratory syncytial virus (RSV) image show?
    This electron microscope image provided by the National Institutes of Health shows human respiratory syncytial virus (RSV) virions, colorized blue, and anti-RSV F protein/gold antibodies, colorized yellow, shedding from the surface of human lung cells.

    US approves 1st vaccine for RSV after decades of attempts

    apnews.com
    What is a colorized electron microscope image of respiratory syncytial virus?
    A colorized electron microscope image of the human respiratory syncytial virus, with virions in blue and antibodies in yellow, shedding from the surface of human lung cells. National Institute of Allergy and Infectious Diseases, via Associated Press Why It Matters: Older adults are at a higher risk.

    FDA Approves Pfizer’s RSV Vaccine for Adults 60 and Older | The New

    nytimes.com
    Feedback
  4. CNN
    https://www.cnn.com/2023/05/03/health/first-rsv-vaccine-approved

    FDA approves first vaccine for RSV, a moment six decades in the

  5. Food and Drug Administration (.gov)
    https://www.fda.gov/news-events/press...

    FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine

  7. NBC News
    https://www.nbcnews.com/health/health-news/fda...

    FDA approves RSV vaccine for adults ages 60 and up - NBC News

  8. AP News
    https://apnews.com/article/rsv-vaccine-respiratory...

    US approves 1st vaccine for RSV after decades of attempts

  9. Los Angeles Times
    https://www.latimes.com/science/story/2023-05-03/...

    FDA approves first vaccine for RSV after decades of attempts

  10. New York Times
    https://www.nytimes.com/2023/05/31/health/fda-rsv...

    FDA Approves Pfizer’s RSV Vaccine for Adults 60 and Older - The …

    Tags:
    Food and Drug Administration
    Pfizer
  11. CDC
    https://www.cdc.gov/media/releases/20…

    CDC Updates RSV Vaccination Recommendation for …

    WEBJun 26, 2024 · Today, CDC updated its recommendation for the use of Respiratory Syncytial Virus (RSV) vaccines in people ages 60 and older. For this upcoming respiratory virus season, CDC recommends: …

  12. The New England Journal of Medicine
    https://www.nejm.org/doi/full/10.1056/NEJ…

    Efficacy and Safety of an mRNA-Based RSV PreF …

    WEBDec 13, 2023 · Respiratory syncytial virus (RSV) can cause substantial morbidity and mortality among older adults. An mRNA-based RSV vaccine, mRNA-1345, encoding the stabilized RSV prefusion F glycoprotein,...

  13. Nature
    https://www.nature.com/articles/d41586 …

    ‘A good day’: FDA approves world’s first RSV vaccine

    WEBMay 3, 2023 · The US Food and Drug Administration (FDA) has approved GSK’s vaccine against respiratory syncytial virus (RSV) for use in people aged 60 years and older. This is the first RSV vaccine to gain...

    Tags:
    Vaccine
    Food and Drug Administration
  14. Nature
    https://www.nature.com/articles/s41591-023-02571-6

    Progress at last against RSV | Nature Medicine

    Tags:
    Nature Medicine
    Human respiratory syncytial virus